Sheela Ramamoorthy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sheela Ramamoorthy has a total of 150 co-authors. Here are the top co-authors by number of shared publications:
- Xiang-Jin Meng
Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA, 24061, USA; Center for Emerging, Zoonotic and Arthropod-Borne Pathogens, Fralin Life Sciences Institute, Virginia Polytechnic Institute and State University, Blacksburg, VA, 24061, USA
15 shared publications - Tanja Opriessnig
Moredun Research Institute
7 shared publications Brett Webb
Veterinary Diagnostic Laboratory, North Dakota State University, Fargo, ND, United States
6 shared publicationsN. Pal
Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, Iowa
6 shared publications- Agm Rakibuzzaman
Department of Microbiological Sciences, North Dakota State University, Fargo, ND 58102, USA
5 shared publications - Angela Pillatzki
Animal Disease Research and Diagnostic Laboratory, South Dakota State University, Brookings, SD 57007, USA
5 shared publications
Latest Publications
- Open Access
- 7 May 2026
- Published by Microbiology Society in Journal of General Virology
- Vol. 107 (5) , 002264
Infectivity of recombinant Torque teno sus virus 1 in pigs coinfected with swine influenza virus
Torque teno viruses (TTVs) are small non-enveloped DNA viruses that are ubiquitous among mammalian species. Although their pathogenic potential remains uncertain, TTVs can modulate host immunity and potentiate coinfecting pathogens or comorbid conditions. Progress in understanding TTV biology has been constrained by the absence of robust in vitro and in vivo experimental systems. To address these limitations, we investigated the infectivity of a recombinant swine TTV [Torque teno sus virus 1 (TTSuV1)] generated with a reverse genetics system in a snatch-farrowed piglet model. Additionally, we evaluated the impact of TTSuV1 coinfection on the pathogenesis and replication dynamics of swine influenza virus (SIV). Infection of piglets with the rescued TTSuV1 induced seroconversion and lymphopenia. Early infection was associated with reduced lymphocyte proliferative responses to mitogens and diminished or absent recall responses to viral antigens. TTSuV1 antigen was detected within immune cell populations by flow cytometry. Contrary to expectations, prior TTSuV1 infection did not significantly exacerbate SIV-associated clinical signs or pulmonary lesions. The use of a snatch-farrowed piglet model in combination with recombinant TTSuV1 derived from reverse genetics provides a controlled system for investigating TTV–host interactions. This approach represents a valuable tool for advancing mechanistic studies of TTV biology and its role in modulating coinfections.
- 7 May 2026
- Published by Microbiology Society in Journal of General Virology
- Vol. 107 (5) , 002264
Open AccessInfectivity of recombinant Torque teno sus virus 1 in pigs coinfected with swine influenza virus
Torque teno viruses (TTVs) are small non-enveloped DNA viruses that are ubiquitous among mammalian species. Although their pathogenic potential remains uncertain, TTVs can modulate host immunity and potentiate coinfecting pathogens or comorbid conditions. Progress in understanding TTV biology has been constrained by the absence of robust in vitro and in vivo experimental systems. To address these limitations, we investigated the infectivity of a recombinant swine TTV [Torque teno sus virus 1 (TTSuV1)] generated with a reverse genetics system in a snatch-farrowed piglet model. Additionally, we evaluated the impact of TTSuV1 coinfection on the pathogenesis and replication dynamics of swine influenza virus (SIV). Infection of piglets with the rescued TTSuV1 induced seroconversion and lymphopenia. Early infection was associated with reduced lymphocyte proliferative responses to mitogens and diminished or absent recall responses to viral antigens. TTSuV1 antigen was detected within immune cell populations by flow cytometry. Contrary to expectations, prior TTSuV1 infection did not significantly exacerbate SIV-associated clinical signs or pulmonary lesions. The use of a snatch-farrowed piglet model in combination with recombinant TTSuV1 derived from reverse genetics provides a controlled system for investigating TTV–host interactions. This approach represents a valuable tool for advancing mechanistic studies of TTV biology and its role in modulating coinfections.
- Open Access
Prior Infection with Torque Teno Virus Mitigates Influenza Pathology in Mice
Respiratory infections caused by influenza viruses are frequently associated with coinfection by other infectious agents. Torque teno viruses (TTVs) are small DNA viruses that can function as opportunistic pathogens and are epidemiologically linked to influenza viruses as well as a broad spectrum of infectious and immune-mediated diseases. Among TTVs, swine torque teno viruses (TTSuVs) are unique in that they have been shown to act as primary pathogens. With the long-term objective of developing experimental tools to better understand inter-viral interactions, this study aimed to optimize a murine model of TTV and influenza virus coinfection. Experimental mice were inoculated with TTSuV1 on day 1 post infection (DPI 1), while phosphate-buffered saline (PBS)-treated mice served as negative controls. A subset of TTSuV1-infected mice was subsequently coinfected with the influenza A virus H1N1 (IAV) at either 12 or 27 days following TTSuV1 infection. An additional group of mice was maintained as an IAV only control. Mice infected with IAV were euthanized 72–84 h post-IAV infection, corresponding to DPI 15 and 30, respectively. Unexpectedly, gross and histopathological examination of lung tissues revealed that prior TTSuV1 infection significantly attenuated IAV-induced pathology in coinfected mice. Coinfected animals also exhibited a tendency toward reduced IAV replication in the lungs as measured by qPCR, TCID50 and HAs compared to mice infected with IAV alone, accompanied by lower levels of virus-specific antibodies to IAV at DPI 30 and TTSuV1 at DPI 15 respectively. At DPI 30, TTSuV1 genomic DNA levels in lung tissue and whole blood were higher in coinfected mice, suggestive of prolonged viremia in the coinfected group. Collectively, these findings establish baseline parameters for a murine TTV and influenza coinfection model and provide a foundation for future studies aimed at elucidating the molecular and immunological mechanisms underlying viral coinfections.
Open AccessPrior Infection with Torque Teno Virus Mitigates Influenza Pathology in Mice
Respiratory infections caused by influenza viruses are frequently associated with coinfection by other infectious agents. Torque teno viruses (TTVs) are small DNA viruses that can function as opportunistic pathogens and are epidemiologically linked to influenza viruses as well as a broad spectrum of infectious and immune-mediated diseases. Among TTVs, swine torque teno viruses (TTSuVs) are unique in that they have been shown to act as primary pathogens. With the long-term objective of developing experimental tools to better understand inter-viral interactions, this study aimed to optimize a murine model of TTV and influenza virus coinfection. Experimental mice were inoculated with TTSuV1 on day 1 post infection (DPI 1), while phosphate-buffered saline (PBS)-treated mice served as negative controls. A subset of TTSuV1-infected mice was subsequently coinfected with the influenza A virus H1N1 (IAV) at either 12 or 27 days following TTSuV1 infection. An additional group of mice was maintained as an IAV only control. Mice infected with IAV were euthanized 72–84 h post-IAV infection, corresponding to DPI 15 and 30, respectively. Unexpectedly, gross and histopathological examination of lung tissues revealed that prior TTSuV1 infection significantly attenuated IAV-induced pathology in coinfected mice. Coinfected animals also exhibited a tendency toward reduced IAV replication in the lungs as measured by qPCR, TCID50 and HAs compared to mice infected with IAV alone, accompanied by lower levels of virus-specific antibodies to IAV at DPI 30 and TTSuV1 at DPI 15 respectively. At DPI 30, TTSuV1 genomic DNA levels in lung tissue and whole blood were higher in coinfected mice, suggestive of prolonged viremia in the coinfected group. Collectively, these findings establish baseline parameters for a murine TTV and influenza coinfection model and provide a foundation for future studies aimed at elucidating the molecular and immunological mechanisms underlying viral coinfections.
- Open Access
Immune Responses and Replication of Rescued Torque Teno Virus (TTSuV1) in Mice
Although Torque Teno Viruses (TTVs) were initially considered to be ubiquitous members of the mammalian virome, the finding that swine TTVs (TTSuV) can act as primary pathogens elevates the possible status of swine TTVs (TTSuVs) to an emerging swine pathogen. Since their discovery, the molecular mechanisms of TTV–host interactions remain largely unknown as robust in vitro culture systems and in vivo animal models have not been available. This study was undertaken to address some of these long-standing gaps. Recombinant TTSuV1 rescued from an infectious clone was used to infect C57BL/J6 mice. Infected mice seroconverted within 15 days post-infection and mounted virus neutralizing antibody responses. Viral DNA was detected in blood and lung tissue for the duration of the study. TTSuV1 isolated from the lung tissue of infected mice productively and serially infected PK-15 cells in vitro, indicating that the treatment produced viable, replicative viral particles in the host. TTSuV1 antigen was also detected by flow cytometry in lymphocytes, including the T and B lymphocyte subsets. Infected mice exhibited mild splenic hyperplasia and lymphopenia. The ability to respond to mitogenic stimuli was highly diminished in infected mice and a striking lack of virus-specific recall responses was observed for the 30-day duration of the study. Therefore, this study is the first to provide experimental evidence that recombinant TTSuV1 rescued from an infectious clone is infective and induces immune responses in laboratory mice. This model provides a critical tool for advancing research on TTV immunopathogenesis.
Open AccessImmune Responses and Replication of Rescued Torque Teno Virus (TTSuV1) in Mice
Although Torque Teno Viruses (TTVs) were initially considered to be ubiquitous members of the mammalian virome, the finding that swine TTVs (TTSuV) can act as primary pathogens elevates the possible status of swine TTVs (TTSuVs) to an emerging swine pathogen. Since their discovery, the molecular mechanisms of TTV–host interactions remain largely unknown as robust in vitro culture systems and in vivo animal models have not been available. This study was undertaken to address some of these long-standing gaps. Recombinant TTSuV1 rescued from an infectious clone was used to infect C57BL/J6 mice. Infected mice seroconverted within 15 days post-infection and mounted virus neutralizing antibody responses. Viral DNA was detected in blood and lung tissue for the duration of the study. TTSuV1 isolated from the lung tissue of infected mice productively and serially infected PK-15 cells in vitro, indicating that the treatment produced viable, replicative viral particles in the host. TTSuV1 antigen was also detected by flow cytometry in lymphocytes, including the T and B lymphocyte subsets. Infected mice exhibited mild splenic hyperplasia and lymphopenia. The ability to respond to mitogenic stimuli was highly diminished in infected mice and a striking lack of virus-specific recall responses was observed for the 30-day duration of the study. Therefore, this study is the first to provide experimental evidence that recombinant TTSuV1 rescued from an infectious clone is infective and induces immune responses in laboratory mice. This model provides a critical tool for advancing research on TTV immunopathogenesis.
- Open Access
- 23 January 2024
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 15, 1326696
Trans-replicase helper activity of porcine circoviruses promotes the synergistic replication of torque teno virus
While the primary pathogenic potential of torque teno viruses (TTVs) is yet to be defined, TTVs are often co-detected with other pathogens and are suspected of exacerbating clinical disease in coinfections. Swine TTVs (TTSuVs) enhance clinical signs of porcine circovirus type 2 (PCV2) in a gnotobiotic pig model. However, the mechanisms involved are unknown. In this study, we observed that co-culture of TTSuV1 and PCV1, and specifically supplementing TTSuV1 cultures with the PCV replicase protein in trans consistently resulted in higher levels of replication of TTSuV1 when compared to TTSuV1 cultured alone. Therefore, the hypothesis that the PCV replicase (rep) protein has trans-replicase helper activity for TTSuV1 was examined. Based on EMSA and reporter gene assays, it was determined that the PCV1 rep directly interacted with the TTSuV1 UTR. The TTSuV1 rep trans-complemented a PCV rep null mutant virus, indicating that the TTSuV1 and PCV1 replicase proteins supported the replication of both viruses. In mice, the administration of plasmids encoding the PCV1 rep and a TTSuV1 infectious clone resulted in the production of higher TTSuV1 genome copies in dually exposed mice when compared to singly exposed mice. Higher sero-conversion and lymphoid hyperplasia were also observed in the dually exposed experimental mice. Thus, this study provides evidence for trans-replicase activity of PCVs and TTVs as a novel mechanism of explaining enhanced viral replication in coinfections involving both viruses.
- 23 January 2024
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 15, 1326696
Open AccessTrans-replicase helper activity of porcine circoviruses promotes the synergistic replication of torque teno virus
While the primary pathogenic potential of torque teno viruses (TTVs) is yet to be defined, TTVs are often co-detected with other pathogens and are suspected of exacerbating clinical disease in coinfections. Swine TTVs (TTSuVs) enhance clinical signs of porcine circovirus type 2 (PCV2) in a gnotobiotic pig model. However, the mechanisms involved are unknown. In this study, we observed that co-culture of TTSuV1 and PCV1, and specifically supplementing TTSuV1 cultures with the PCV replicase protein in trans consistently resulted in higher levels of replication of TTSuV1 when compared to TTSuV1 cultured alone. Therefore, the hypothesis that the PCV replicase (rep) protein has trans-replicase helper activity for TTSuV1 was examined. Based on EMSA and reporter gene assays, it was determined that the PCV1 rep directly interacted with the TTSuV1 UTR. The TTSuV1 rep trans-complemented a PCV rep null mutant virus, indicating that the TTSuV1 and PCV1 replicase proteins supported the replication of both viruses. In mice, the administration of plasmids encoding the PCV1 rep and a TTSuV1 infectious clone resulted in the production of higher TTSuV1 genome copies in dually exposed mice when compared to singly exposed mice. Higher sero-conversion and lymphoid hyperplasia were also observed in the dually exposed experimental mice. Thus, this study provides evidence for trans-replicase activity of PCVs and TTVs as a novel mechanism of explaining enhanced viral replication in coinfections involving both viruses.
- Open Access
- 12 April 2022
- Published by Oxford University Press (OUP) in Journal of Animal Science
- Vol. 100 (Supplement) , 5-6
10 Development of an Essential Oil-Based Intranasal Spray Against Bovine Respiratory Pathogens: in vitro Selection Based on Antimicrobial, Antiviral, Immunomodulatory, and Antibiofilm Activities
The objective of this study was to screen and select candidate essential oils (EOs) for the development of an intranasal EO spray against bacterial and viral pathogens associated with bovine respiratory disease (BRD) as an alternative to antibiotics. The effects of previously selected EOs (N = 6; ajowan, cinnamon leaf, citronella, grapefruit, fennel, and thyme) on bovine nasopharyngeal microbiota culture was evaluated using 16S rRNA gene sequencing. The microbiota culture was prepared by growing nasopharyngeal swabs obtained from finishing beef heifers in brain heart infusion broth with and without the presence of EOs (0.025%, vol/vol). The sequencing was performed on genomic DNA extracted from the microbiota culture harvested after 24 h incubation. These EOs were then evaluated for their immunomodulation effect on bovine turbinate (BT) cells by analyzing the concentrations of 15 cytokines and chemokines in cell culture after 24 h incubation. The EOs were further characterized by assessing their antibiofilm activity against E. coli UMN026 using a crystal violet assay. Finally, 15 EOs were screened for their antiviral activity against the bovine viral diarrhea virus 1 (BVDV1) using BT cells and a fluorescence-based method. Ajowan, fennel, and thyme resulted in a moderate reduction of overall nasopharyngeal microbiota growth, and significant alterations of both α- and β-diversity, and relative abundance of predominant bacterial families (e.g., boosting Enterobacteriaceae while suppressing Moraxellaceae) compared with control (P < 0.05). Only IL-6 and IL-8 cytokine concentrations were affected by EOs (P < 0.05). Ajowan, thyme, fennel, and cinnamon leaf exhibited antibiofilm activity at the concentration of 0.05%. Reduction of BVDV1 viral replication on BT cells was observed with thyme (strong), ajowan, and citronella (moderate; 0.0125%). Accordingly, ajowan, thyme, fennel, cinnamon leaf, and citronella EOs were selected for development as an intranasal EO spray to prevent and control BRD pathogens in feedlot cattle.
- 12 April 2022
- Published by Oxford University Press (OUP) in Journal of Animal Science
- Vol. 100 (Supplement) , 5-6
Open Access10 Development of an Essential Oil-Based Intranasal Spray Against Bovine Respiratory Pathogens: in vitro Selection Based on Antimicrobial, Antiviral, Immunomodulatory, and Antibiofilm Activities
The objective of this study was to screen and select candidate essential oils (EOs) for the development of an intranasal EO spray against bacterial and viral pathogens associated with bovine respiratory disease (BRD) as an alternative to antibiotics. The effects of previously selected EOs (N = 6; ajowan, cinnamon leaf, citronella, grapefruit, fennel, and thyme) on bovine nasopharyngeal microbiota culture was evaluated using 16S rRNA gene sequencing. The microbiota culture was prepared by growing nasopharyngeal swabs obtained from finishing beef heifers in brain heart infusion broth with and without the presence of EOs (0.025%, vol/vol). The sequencing was performed on genomic DNA extracted from the microbiota culture harvested after 24 h incubation. These EOs were then evaluated for their immunomodulation effect on bovine turbinate (BT) cells by analyzing the concentrations of 15 cytokines and chemokines in cell culture after 24 h incubation. The EOs were further characterized by assessing their antibiofilm activity against E. coli UMN026 using a crystal violet assay. Finally, 15 EOs were screened for their antiviral activity against the bovine viral diarrhea virus 1 (BVDV1) using BT cells and a fluorescence-based method. Ajowan, fennel, and thyme resulted in a moderate reduction of overall nasopharyngeal microbiota growth, and significant alterations of both α- and β-diversity, and relative abundance of predominant bacterial families (e.g., boosting Enterobacteriaceae while suppressing Moraxellaceae) compared with control (P < 0.05). Only IL-6 and IL-8 cytokine concentrations were affected by EOs (P < 0.05). Ajowan, thyme, fennel, and cinnamon leaf exhibited antibiofilm activity at the concentration of 0.05%. Reduction of BVDV1 viral replication on BT cells was observed with thyme (strong), ajowan, and citronella (moderate; 0.0125%). Accordingly, ajowan, thyme, fennel, cinnamon leaf, and citronella EOs were selected for development as an intranasal EO spray to prevent and control BRD pathogens in feedlot cattle.
- Open Access
Harnessing the Genetic Plasticity of Porcine Circovirus Type 2 to Target Suicidal Replication
Porcine circovirus type 2 (PCV2), the causative agent of a wasting disease in weanling piglets, has periodically evolved into several new subtypes since its discovery, indicating that the efficacy of current vaccines can be improved. Although a DNA virus, the mutation rates of PCV2 resemble RNA viruses. The hypothesis that recoding of selected serine and leucine codons in the PCV2b capsid gene could result in stop codons due to mutations occurring during viral replication and thus result in rapid attenuation was tested. Vaccination of weanling pigs with the suicidal vaccine constructs elicited strong virus-neutralizing antibody responses. Vaccination prevented lesions, body-weight loss, and viral replication on challenge with a heterologous PCV2d strain. The suicidal PCV2 vaccine construct was not detectable in the sera of vaccinated pigs at 14 days post-vaccination, indicating that the attenuated vaccine was very safe. Exposure of the modified virus to immune selection pressure with sub-neutralizing levels of antibodies resulted in 5 of the 22 target codons mutating to a stop signal. Thus, the described approach for the rapid attenuation of PCV2 was both effective and safe. It can be readily adapted to newly emerging viruses with high mutation rates to meet the current need for improved platforms for rapid-response vaccines.
Open AccessHarnessing the Genetic Plasticity of Porcine Circovirus Type 2 to Target Suicidal Replication
Porcine circovirus type 2 (PCV2), the causative agent of a wasting disease in weanling piglets, has periodically evolved into several new subtypes since its discovery, indicating that the efficacy of current vaccines can be improved. Although a DNA virus, the mutation rates of PCV2 resemble RNA viruses. The hypothesis that recoding of selected serine and leucine codons in the PCV2b capsid gene could result in stop codons due to mutations occurring during viral replication and thus result in rapid attenuation was tested. Vaccination of weanling pigs with the suicidal vaccine constructs elicited strong virus-neutralizing antibody responses. Vaccination prevented lesions, body-weight loss, and viral replication on challenge with a heterologous PCV2d strain. The suicidal PCV2 vaccine construct was not detectable in the sera of vaccinated pigs at 14 days post-vaccination, indicating that the attenuated vaccine was very safe. Exposure of the modified virus to immune selection pressure with sub-neutralizing levels of antibodies resulted in 5 of the 22 target codons mutating to a stop signal. Thus, the described approach for the rapid attenuation of PCV2 was both effective and safe. It can be readily adapted to newly emerging viruses with high mutation rates to meet the current need for improved platforms for rapid-response vaccines.
- 20 July 2021
- Published by Hindawi Limited in Transboundary and Emerging Diseases
- Vol. 68 (6) , 2957-2968
Comparative immunopathogenesis and biology of recently discovered porcine circoviruses
Porcine circoviruses are important pathogens of production swine. Porcine circovirus type 1 (PCV1) is non-pathogenic, and discovered as a contaminant of a porcine kidney cell line, PK-15. The discovery of pathogenic variant, PCV2, occurred in the late 90s in association with post-weaning multi-systemic wasting disease syndrome (PMWS), which is characterized by wasting, respiratory signs and lymphadenopathy in weanling pigs. A new PCV type, designated as PCV3, was discovered in 2016, in pigs manifesting porcine dermatitis and nephropathy syndrome (PDNS), respiratory distress and reproductive failure. Pathological manifestations of PCV3 Infections include systemic inflammation, vasculitis and myocarditis. A fourth PCV type, PCV4, was identified in 2020 in pigs with PDNS, respiratory and enteric signs. All the pathogenic PCV types are detected in both healthy and morbid pigs. They cause chronic, systemic infections with various clinical manifestations. Dysregulation of the immune system homeostasis is a pivotal trigger for pathogenesis in porcine circoviral infections. While the study of PCV3 immunobiology is still in its infancy lessons learned from PCV2 and other circular replication-associated protein (Rep)-encoding single stranded (ss) (CRESS) DNA viruses can inform the field of exploration for PCV3. Viral interactions with the innate immune system, interference with dendritic cell function coupled with the direct loss of lymphocytes compromises both innate and adaptive immunity in PCV2 infections. Dysregulated immune responses leading to the establishment of a pro-inflammatory state, immune complex associated hypersensitivity, and the necrosis of lymphocytes and immune cells are key features of PCV3 immunopathogenesis. A critical overview of the comparative immunopathology of PCV2 and PCV3/4, and directions for future research in the field are presented in this review.
- 20 July 2021
- Published by Hindawi Limited in Transboundary and Emerging Diseases
- Vol. 68 (6) , 2957-2968
Comparative immunopathogenesis and biology of recently discovered porcine circoviruses
Porcine circoviruses are important pathogens of production swine. Porcine circovirus type 1 (PCV1) is non-pathogenic, and discovered as a contaminant of a porcine kidney cell line, PK-15. The discovery of pathogenic variant, PCV2, occurred in the late 90s in association with post-weaning multi-systemic wasting disease syndrome (PMWS), which is characterized by wasting, respiratory signs and lymphadenopathy in weanling pigs. A new PCV type, designated as PCV3, was discovered in 2016, in pigs manifesting porcine dermatitis and nephropathy syndrome (PDNS), respiratory distress and reproductive failure. Pathological manifestations of PCV3 Infections include systemic inflammation, vasculitis and myocarditis. A fourth PCV type, PCV4, was identified in 2020 in pigs with PDNS, respiratory and enteric signs. All the pathogenic PCV types are detected in both healthy and morbid pigs. They cause chronic, systemic infections with various clinical manifestations. Dysregulation of the immune system homeostasis is a pivotal trigger for pathogenesis in porcine circoviral infections. While the study of PCV3 immunobiology is still in its infancy lessons learned from PCV2 and other circular replication-associated protein (Rep)-encoding single stranded (ss) (CRESS) DNA viruses can inform the field of exploration for PCV3. Viral interactions with the innate immune system, interference with dendritic cell function coupled with the direct loss of lymphocytes compromises both innate and adaptive immunity in PCV2 infections. Dysregulated immune responses leading to the establishment of a pro-inflammatory state, immune complex associated hypersensitivity, and the necrosis of lymphocytes and immune cells are key features of PCV3 immunopathogenesis. A critical overview of the comparative immunopathology of PCV2 and PCV3/4, and directions for future research in the field are presented in this review.
- Open Access
Targeted Alteration of Antibody-Based Immunodominance Enhances the Heterosubtypic Immunity of an Experimental PCV2 Vaccine
Despite the availability of commercial vaccines which can effectively prevent clinical signs, porcine circovirus type 2 (PCV2) continues to remain an economically important swine virus, as strain drift, followed by displacement of new subtypes, occurs periodically. We had previously determined that the early antibody responses to the PCV2 capsid protein in infected pigs map to immunodominant but non-protective, linear B cell epitopes. In this study, two of the previously identified immunodominant epitopes were mutated in the backbone of a PCV2b infectious clone, to rationally restructure the immunogenic capsid protein. The rescued virus was used to immunize 3-week-old weanling piglets, followed by challenge with a virulent heterologous PCV2d strain. As expected, immunodominant antibody responses to the targeted epitopes were abrogated in vaccinated pigs, while a broadening of the virus neutralization responses was detected. Vaccinated pigs were completely protected against challenge viral replication, had reduced microscopic lesions in lymphoid organs and gained significantly more body weight when compared to unvaccinated pigs. Thus, the experimental PCV2 vaccine developed was highly effective against challenge, and, if adopted commercially, can potentially slow down or eliminate new strain creation.
Open AccessTargeted Alteration of Antibody-Based Immunodominance Enhances the Heterosubtypic Immunity of an Experimental PCV2 Vaccine
Despite the availability of commercial vaccines which can effectively prevent clinical signs, porcine circovirus type 2 (PCV2) continues to remain an economically important swine virus, as strain drift, followed by displacement of new subtypes, occurs periodically. We had previously determined that the early antibody responses to the PCV2 capsid protein in infected pigs map to immunodominant but non-protective, linear B cell epitopes. In this study, two of the previously identified immunodominant epitopes were mutated in the backbone of a PCV2b infectious clone, to rationally restructure the immunogenic capsid protein. The rescued virus was used to immunize 3-week-old weanling piglets, followed by challenge with a virulent heterologous PCV2d strain. As expected, immunodominant antibody responses to the targeted epitopes were abrogated in vaccinated pigs, while a broadening of the virus neutralization responses was detected. Vaccinated pigs were completely protected against challenge viral replication, had reduced microscopic lesions in lymphoid organs and gained significantly more body weight when compared to unvaccinated pigs. Thus, the experimental PCV2 vaccine developed was highly effective against challenge, and, if adopted commercially, can potentially slow down or eliminate new strain creation.
- 1 August 2020
- Published by Elsevier in Virus Research
- Vol. 285, 198013
Torque teno viruses in health and disease
- 1 August 2020
- Published by Elsevier in Virus Research
- Vol. 285, 198013
Torque teno viruses in health and disease